Source: BEFREE
Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MPL proto-oncogene, thrombopoietin receptor | 0.510 | 0.692 | 4.1E-09 |
|
disease | 0.500 | None | 0.979 | 91 | 4 | 1995 | 2020 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.480 | None | 1.000 | 8 | 0 | 1994 | 2015 | ||||||||
|
centromere protein E | 0.636 | 0.692 | 0.24 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
DNA ligase 4 | 0.478 | 0.846 | 4.2E-06 |
|
disease | 0.310 | strong | 1.000 | 1 | 0 | 2001 | 2015 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
disease | 0.300 | None | 0.979 | 516 | 12 | 2005 | 2020 | ||||||||
|
platelet derived growth factor receptor beta | 0.416 | 0.846 | 0.90 |
|
disease | 0.300 | None | 1.000 | 24 | 0 | 2003 | 2019 | ||||||||
|
ASXL transcriptional regulator 1 | 0.482 | 0.808 | 1.3E-14 |
|
disease | 0.300 | None | 1.000 | 13 | 0 | 2010 | 2019 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
disease | 0.100 | None | 0.975 | 159 | 0 | 1993 | 2020 | ||||||||
|
calreticulin | 0.413 | 0.923 | 0.89 |
|
disease | 0.100 | None | 0.980 | 102 | 0 | 2014 | 2020 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
disease | 0.100 | None | 0.942 | 69 | 0 | 1992 | 2019 | ||||||||
|
fibroblast growth factor receptor 1 | 0.362 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 34 | 0 | 1998 | 2018 | ||||||||
|
sterol O-acyltransferase 1 | 0.424 | 0.846 | 7.4E-10 |
|
disease | 0.100 | None | 1.000 | 33 | 0 | 2006 | 2020 | ||||||||
|
tet methylcytosine dioxygenase 2 | 0.458 | 0.808 | 4.3E-54 |
|
disease | 0.100 | None | 0.958 | 24 | 1 | 2009 | 2019 | ||||||||
|
CD34 molecule | 0.368 | 0.808 | 5.0E-06 |
|
disease | 0.100 | None | 1.000 | 17 | 0 | 2008 | 2016 | ||||||||
|
platelet derived growth factor receptor alpha | 0.415 | 0.808 | 1.00 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 2003 | 2018 | ||||||||
|
signal transducer and activator of transcription 5B | 0.442 | 0.808 | 1.00 |
|
disease | 0.100 | None | 1.000 | 13 | 0 | 2008 | 2018 | ||||||||
|
signal transducer and activator of transcription 5A | 0.445 | 0.808 | 1.00 |
|
disease | 0.100 | None | 1.000 | 13 | 0 | 2008 | 2018 | ||||||||
|
fms related receptor tyrosine kinase 3 | 0.462 | 0.654 | 0.61 |
|
disease | 0.100 | None | 1.000 | 12 | 0 | 2002 | 2016 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.100 | None | 0.917 | 12 | 0 | 1993 | 2019 | ||||||||
|
Janus kinase 1 | 0.474 | 0.769 | 1.00 |
|
disease | 0.100 | None | 1.000 | 12 | 0 | 2009 | 2019 | ||||||||
|
Cbl proto-oncogene | 0.527 | 0.769 | 6.1E-04 |
|
disease | 0.100 | None | 0.909 | 11 | 0 | 2009 | 2016 | ||||||||
|
protein tyrosine phosphatase non-receptor type 11 | 0.385 | 0.923 | 1.00 |
|
disease | 0.100 | None | 0.909 | 11 | 3 | 2005 | 2018 | ||||||||
|
RUNX family transcription factor 1 | 0.425 | 0.808 | 0.65 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 2001 | 2016 | ||||||||
|
SH2B adaptor protein 3 | 0.527 | 0.692 | 1.0E-04 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2010 | 2017 | ||||||||
|
thrombopoietin | 0.513 | 0.692 | 0.20 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1995 | 2020 |